List of news
1) GSK supports Mercury Drug's Bigay Lunas in providing medicines to 27,500 families
2) GSK Supports Mass Drug Administration for Filariasis Elimination in Davao City
3) GSK Brings New Hope to Advanced Breast Cancer Patients with breakthrough drug
4) GSK Global Manufacturing Supply – Cainta signs CBA in record time
5) Targeted Therapy brings new hope for advanced breast cancer patients
6) Top Collegiates match wits in GSK’s Enterprise
7) GSK employee vaccination: Caring begins at home
8) GSK Employees do more, feel better, live longer at annual Health & Safety Week
Back to top
GSK at a glance
We are the only pharmaceutical company to tackle the three "priority" diseases identified by the World Health Organization: HIV/AIDS, tuberculosis and malaria Our business employs over 100,000 people in 117 countries We make almost four billion packs of medicines and healthcare products every year We screen about 65 million compounds every year in our search for new medicines We supply one quarter of the world's vaccines and by the end of 2007 we had 23 vaccines in clinical development To date, we have donated over 750 million albendazole tablets to help elimitate lymphatic filariasis (elephantiasis) in the world In 2006 we shipped 126 million tablets of preferentially-priced Combivir and Epivir (our HIV treatments) to developing countries Almost 100 countries benefitted from our humanitarian product donations